Dungog, Argie Lou .
HRN: 24-08-63 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/11/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/11/2023
12/18/2023
IV
1.5g
Q6hours
T/c Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes